Mohamed Kharfan-Dabaja: The largest experience of autologous hematopoietic cell transplantation
Mohamed Kharfan-Dabaja, Vice Chair of Hematology at Mayo Clinic Comprehensive Cancer Center, shared a post on X about recent paper he and colleagues co-authored, titled “Early morbimortality in autologous hematopoietic cell transplantation performed on outpatient basis in patients with autoimmune diseases: experience in 1700 patients” published on Bone Marrow Transplantation.
Authors: Olivia Lira-Lara, Max Robles-Nasta, Juan Carlos Olivares-Gazca, Mohamed Kharfan-Dabaja, Montserrat Rivera-Álvarez, Danae García-Vélez, Michelle Lavoignet-Cisneros, Mónica D. Salgado-Cabrera, David Gomez-Almaguer, Andrés Gómez-De-León, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles
“The largest experience of autologous hematopoietic cell transplantation in 1700 patients with autoimmune diseases, in the outpatient setting, using the ‘Mexican method’. ‘Yes, it can be done'”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023